196 related articles for article (PubMed ID: 9601480)
21. Mechanisms of action of novel cardiotonic agents.
Endoh M
J Cardiovasc Pharmacol; 2002 Sep; 40(3):323-38. PubMed ID: 12198318
[TBL] [Abstract][Full Text] [Related]
22. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
Brixius K; Reicke S; Reuter H; Schwinger RH
Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
[TBL] [Abstract][Full Text] [Related]
23. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
[TBL] [Abstract][Full Text] [Related]
24. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
25. Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET.
Sprenger JU; Bork NI; Herting J; Fischer TH; Nikolaev VO
PLoS One; 2016; 11(12):e0167974. PubMed ID: 27930744
[TBL] [Abstract][Full Text] [Related]
26. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
Hsu CH; Wei J; Chen YC; Yang SP; Tsai CS; Lin CI
J Heart Lung Transplant; 2006 Sep; 25(9):1126-34. PubMed ID: 16962476
[TBL] [Abstract][Full Text] [Related]
27. Effects of OR-1896, an active metabolite of levosimendan, on contractile force and aequorin light transients in intact rabbit ventricular myocardium.
Takahashi R; Talukder MA; Endoh M
J Cardiovasc Pharmacol; 2000 Jul; 36(1):118-25. PubMed ID: 10892669
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of positive inotropic effects.
Scholz H
Basic Res Cardiol; 1989; 84 Suppl 1():3-7. PubMed ID: 2554873
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium.
von Lewinski D; Voss K; Hülsmann S; Kögler H; Pieske B
Circ Res; 2003 Feb; 92(2):169-76. PubMed ID: 12574144
[TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of positive inotropic activity of Ro 13-6438, a structurally novel cardiotonic agent with vasodilating properties.
Holck M; Thorens S; Muggli R; Eigenmann R
J Cardiovasc Pharmacol; 1984; 6(3):520-30. PubMed ID: 6202981
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological effects of ATI22-107 [2-(2-{2-[2-chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester)], a novel dual pharmacophore, on myocyte calcium cycling and contractility.
Jung AS; Quaile MP; Mills GD; Bednarik DP; Houser SR; Margulies KB
J Pharmacol Exp Ther; 2005 Feb; 312(2):517-24. PubMed ID: 15550574
[TBL] [Abstract][Full Text] [Related]
32. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
33. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N; Blinks JR
Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
[TBL] [Abstract][Full Text] [Related]
34. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
Kelso EJ; McDermott BJ; Silke B
Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
[TBL] [Abstract][Full Text] [Related]
35. Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors.
Endoh M; Blinks JR
Circ Res; 1988 Feb; 62(2):247-65. PubMed ID: 2827909
[TBL] [Abstract][Full Text] [Related]
36. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide.
Szokodi I; Kinnunen P; Tavi P; Weckström M; Tóth M; Ruskoaho H
Circulation; 1998 Mar; 97(11):1062-70. PubMed ID: 9531253
[TBL] [Abstract][Full Text] [Related]
37. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization.
Bowman P; Haikala H; Paul RJ
J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786
[TBL] [Abstract][Full Text] [Related]
38. Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.
Nagai K; Murakami T; Iwase T; Tomita T; Sasayama S
J Clin Invest; 1996 Jan; 97(1):6-13. PubMed ID: 8550851
[TBL] [Abstract][Full Text] [Related]
39. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z
J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle.
Sawada H; Endoh M
J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
